Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026
Microbot Medical Inc. announced more than 100% growth in revenue and new customers in Q2 2026, driven by increased adoption of its LIBERTY Endovascular Robotic System following the full market release. The company expanded its U.S. sales territories from 4 to 8 and plans to reach 12 by year's end. They also secured market clearance in Israel and ag…